Effects of statin therapy on augmentation index as a measure of arterial stiffness: A systematic review and meta-analysis

International Journal of Cardiology

Volumn 212, Issue , 2016, Pages 160-168

  Sahebkar, Amirhossein ^a,b   Pećin, Ivan ^c   Tedeschi Reiner, Eugenia ^d   Derosa, Giuseppe ^e   Maffioli, Pamela ^e   Reiner, Željko ^c,d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c KBC Zagreb   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ARTERIAL STIFFNESS; ATHEROSCLEROSIS; AUGMENTATION INDEX; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDICATION; HUMAN; META ANALYSIS; PLEIOTROPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; DRUG EFFECTS; FEMALE; MALE; METABOLISM; STATISTICAL MODEL;

CHOLESTEROL, LDL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIKELIHOOD FUNCTIONS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASCULAR STIFFNESS;

EID: 84961875400     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.03.010     Document Type: Review

References (59)

1. S. Laurent, J. Cockcroft, L. Van Bortel, P. Boutouyrie, C. Giannattasio, D. Hayoz, and et al. European network for non-invasive investigation of large arteries. expert consensus document on arterial stiffness: Methodological issues and clinical applications Eur. Heart J. 27 21 2006 2588 25605
2. C. Vlachopoulos, K. Aznaouridis, and C. Stefanadis Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis J. Am. Coll. Cardiol. 55 13 2010 1318 1327
3. G. Mancia, R. Fagard, K. Narkiewicz, and et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J. 34 28 2013 2159 2219
4. European Association for Cardiovascular Prevention & Rehabilitation, Z. Reiner, Catapano AL, G. De Backer, and et al. ESC/EAS Guidelines for the management of dyslipidaemias: The task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur. Heart J. 32 14 2011 1769 1818
5. J. Perk, G. De Backer, H. Gohlke, and et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). the fifth joint task force of the European Society of Cardiology and Other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur. Heart J. 33 13 2012 1635 1701
6. L.S. Tam, E.K. Li, Q. Shang, B. Tomlinson, V.W. Lee, K.K. Lee, and et al. Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: A randomized controlled pilot trial Scand. J. Rheumatol. 40 6 2011 411 421
7. C. Serban, A. Sahebkar, S. Ursoniu, D.P. Mikhailidis, M. Rizzo, G.Y. Lip, and et al. A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations Sci. Rep. 5 2015 9902
8. S.M. Wallace, K.M. Mäki-Petäjä, J. Cheriyan, E.H. Davidson, L. Cherry, C.M. McEniery, and et al. Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction Br. J. Clin. Pharmacol. 70 6 2010 799 806
9. A. Sahebkar, J. Rathouska, L.E. Simental-Mendía, and P. Nachtigal Statin therapy and plasma cortisol concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials Pharmacol. Res. 103 2016 17 25
10. S.M. Parizadeh, M.R. Azarpazhooh, M. Moohebati, M. Nematy, M. Ghayour-Mobarhan, S. Tavallaie, and et al. Simvastatin therapy reduces prooxidant-antioxidant balance: Results of a placebo-controlled cross-over trial Lipids 46 4 2011 333 340
11. G. Ferretti, T. Bacchetti, and A. Sahebkar Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials Prog. Lipid Res. 60 2015 50 73
12. A. Sahebkar, C. Serban, D.P. Mikhailidis, A. Undas, G.Y. Lip, P. Muntner, and et al. Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Association between statin use and plasma d-dimer levels: A systematic review and meta-analysis of randomised controlled trials Thromb. Haemost. 114 3 2015 546 557
13. H. Takagi, and T. Umemoto Atorvastatin therapy reduces serum uric acid levels: A meta-analysis of randomized controlled trials Int. J. Cardiol. 157 2 2012 255 257
14. J. Raison, A. Rudnichi, and M.E. Safar Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: A preliminary study J. Hum. Hypertens. 16 10 2002 705 710
15. C. Ott, M.P. Schneider, M.P. Schlaich, and R.E. Schmieder Rosuvastatin improves pulse wave reflection by restoring endothelial function Microvasc. Res. 84 1 2012 60 64
16. F.H. Mose, T. Larsen, J.M. Jensen, A.B. Hansen, J.N. Bech, and E.B. Pedersen Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease Br. J. Clin. Pharmacol. 78 4 2014 789 799
17. K.M. Mäki-Petäjä, A.D. Booth, F.C. Hall, S.M. Wallace, J. Brown, C.M. McEniery, and et al. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis J. Am. Coll. Cardiol. 50 9 2007 852 858
18. M.J. Haller, J.M. Stein, J.J. Shuster, D. Theriaque, M.M. Samyn, C. Pepine, and et al. Pediatric atorvastatin in diabetes trial (PADIT): A pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus J. Pediatr. Endocrinol. Metab. 22 1 2009 65 68
19. R.G. Fassett, I.K. Robertson, M.J. Ball, D.P. Geraghty, J.E. Sharman, and J.S. Coombes Effects of atorvastatin on arterial stiffness in chronic kidney disease: A randomised controlled trial J. Atheroscler. Thromb. 17 3 2010 235 241
20. K. Ballard, B.A. Taylor, J.A. Capizi, and et al. Atorvastatin treatment does not alter pulse wave velocity in healthy adults volume International Scholarly Research Notices 2014 239575
21. D. Moher, A. Liberati, J. Tetzlaff, and Altman DG PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement BMJ 339 2009 b2535
22. J.P.T. Higgins, and S. Green Eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 2009 The Cochrane Collaboration London
23. M. Borenstein, L. Hedges, J. Higgins, and et al. Comprehensive Meta-Analysis Version 2 2005 Biostat Englewood NJ
24. X. Wan, W. Wang, J. Liu, and T. Tong Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range BMC Med. Res. Methodol. 14 2014 135
25. S. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med. Res. Methodol. 5 2005 13
26. A.J. Sutton, K.R. Abrams, D.R. Jones, and et al. Methods for Meta-Analysis in Medical Research 2000 John Wiley & Sons West Sussex
27. M. Banach, C. Serban, S. Ursoniu, J. Rysz, P. Muntner, P.P. Toth, and et al. Statin therapy and plasma coenzyme Q10 concentrations - A systematic review and meta-analysis of placebo-controlled trials Pharmacol. Res. 99 2015 329 336
28. A. Sahebkar Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? evidence from a meta-analysis Phytother. Res. 28 5 2014 633 642
29. S. Duval, and R. Tweedie Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2 2000 455 463
30. B. Williams, P.S. Lacy, J.K. Cruickshank, D. Collier, A.D. Hughes, A. Stanton, and et al. CAFE and ASCOT investigators. Impact of statin therapy on central aortic pressures and hemodynamics: Principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study Circulation 119 1 2009 53 61
31. S.J. Leslie, J.C. Spratt, L. Grieg, T. Attina, M.A. Denvir, and D.J. Webb The effect of cerivastatin therapy on vascular responses to endothelin antagonists in humans J. Cardiovasc. Pharmacol. 44 Suppl. 1 2004 S410 S412
32. C. Manisty, J. Mayet, R.J. Tapp, P.S. Sever, N. Poulter, S.A. McG Thom, and et al. ASCOT investigators. Atorvastatin treatment is associated with less augmentation of the carotid pressure waveform in hypertension: A substudy of the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT) Hypertension 54 5 2009 1009 1013
33. D. Trivedi, M. Kirby, D.M. Wellsted, S. Ali, G. Hackett, B. O'Connor, and et al. Can simvastatin improve erectile function and health-related quality of life in men aged ≥ 40 years with erectile dysfunction? Results of the erectile dysfunction and statins trial [ISRCTN66772971] BJU Int. 111 2 2013 324 333
34. T. Iketani, K. Takazawa, and A. Yamashina Effect of eicosapentaenoic acid on central systolic blood pressure Prostaglandins Leukot. Essent. Fatty Acids 88 2 2013 191 195
35. S.J. Hong, H.J. Chang, S. Park, D.R. Kang, S. Shin, I.J. Cho, and et al. Impact of atorvastatin treatment in first-degree relatives of patients with premature coronary artery disease with endothelial dysfunction: A double-blind, randomized, placebo-controlled crossover trial Clin. Cardiol. 36 8 2013 480 485
36. S. Efrati, M. Averbukh, V. Dishy, M. Faygenzo, L. Friedensohn, and A. Golik The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers Eur. J. Clin. Pharmacol. 63 2 2007 113 121
37. R.G. Casey, M. Joyce, K. Moore, C. Thompson, P. Fitzgerald, and D.J. Bouchier-Hayes Two-week treatment with pravastatin improves ventriculo-vascular haemodynamic interactions in young men with type 1 diabetes Diab. Vasc. Dis. Res. 4 1 2007 53 61
38. A.I. Kanaki, P.A. Sarafidis, P.I. Georgianos, K. Kanavos, I.M. Tziolas, P.E. Zebekakis, and et al. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia Am. J. Hypertens. 26 5 2013 608 616
39. Ž. Reiner Statins in the primary prevention of cardiovascular disease Nat. Rev. Cardiol. 10 8 2013 453 464
40. Q. Zhou, and J.K. Liao Pleiotropic effects of statins: Basic research and clinical perspectives Circ. J. 74 5 2010 818 826
41. J.K. Liao, and U. Laufs Pleiotropic effects of statins Annu. Rev. Pharmacol. Toxicol. 45 2005 89 118
42. M. Essig, G. Nguyen, D. Prié, B. Escoubet, J.D. Sraer, and G. Friedlander 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins Circ. Res. 83 1998 683 690
43. N.P. Kadoglou, G.S. Sfyroeras, A. Spathis, C. Gkekas, A. Gastounioti, G. Mantas, and et al. Galectin-3, carotid plaque vulnerability, and potential effects of statin therapy Eur. J. Vasc. Endovasc. Surg. 49 1 2015 4 9
44. N.P. Kadoglou, N. Sailer, A. Moumtzouoglou, A. Kapelouzou, T. Gerasimidis, and C.D. Liapis Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization J. Vasc. Surg. 51 1 2010 114 121
45. C. Vlachopoulos, P. Xaplanteris, V. Aboyans, and et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society Atherosclerosis 241 2 2015 507 532
46. Brown M.J. Yasmin Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness QJM 92 10 1999 595 600
47. A.M. Litz, and G.P. Van Guilder Increased arterial stiffness in South Dakota American Indian children Appl. Physiol. Nutr. Metab. 41 2 2016 Feb 150 156 10.1139/apnm-2015-0426 Epub 2015 Oct 21
48. P.S. Gurunathrao, A. Manjunatha, and D.K. Kanti Evaluation of arterial stiffness in elderly with prehypertension Indian J. Physiol. Pharmacol. 59 1 2015 Jan-Mar 16 22
49. W.W. Nichols, S.J. Denardo, J.B. Davidson, and et al. Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: An ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) Am. Heart J. 170 6 2015 Dec 1243 1254 10.1016/j.ahj.2015.08.019 Epub 2015 Aug 28
50. T.G. Papaioannou, C. Vlachopoulos, and D. Tousoulis Disassociation of aortic pulse wave velocity and augmentation index in patients with metabolic syndrome: Should we blame inflammation? Blood Press Dec 23 2015 1 2 [Epub ahead of print]
51. H. Yanai Correlations of arterial stiffness and augmentation index with metabolic risk factors in patients with type 2 diabetes J. Clin. Hypertens. 2015 10.1111/jch.12728
52. J. Muramatsu, A. Kobayashi, N. Hasegawa, and S. Yokouchi Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin Atherosclerosis 130 1-2 1997 179 182
53. C.H. Chen, C.T. Ting, A. Nussbacher, E. Nevo, D.A. Kass, P. Pak, and et al. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure Hypertension 27 2 1996 168 175
54. A. Sahebkar, G.T. Chew, and G.F. Watts Recent advances in pharmacotherapy for hypertriglyceridemia Prog. Lipid Res. 56 2014 47 66
55. A. Sahebkar, G.T. Chew, and G.F. Watts New peroxisome proliferator-activated receptor agonists: Potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease Expert. Opin. Pharmacother. 15 4 2014 493 503
56. A. Sahebkar, and G.F. Watts New LDL-cholesterol lowering therapies: Pharmacology, clinical trials, and relevance to acute coronary syndromes Clin. Ther. 35 8 2013 1082 1098
57. A. Sahebkar, and G.F. Watts New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: What can the clinician expect? Cardiovasc. Drugs Ther. 27 6 2013 559 567
58. M. Banach, W.S. Aronow, C. Serban, A. Sahabkar, J. Rysz, L. Voroneanu, and et al. Lipids, blood pressure and kidney update 2014 Pharmacol. Res. 95-96 2015 111 125
59. A. Sahebkar, and G.F. Watts Role of selective peroxisome proliferator-activated receptor modulators in managing cardiometabolic disease: Tale of a roller-coaster Diabetes Obes. Metab. 16 9 2014 780 792